NCT05126043已完成不适用
Triglyceride/High Density Lipoprotein-cholesterol Ratio as a Novel Marker of Atherosclerosis in Patients With Acute Coronary Syndrome
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Coronary care unit admission
研究概览
简要总结
This study aims to assess the TG/Hdl-c ratio in patients with acute coronary syndrome as a novel marker of atherosclerosis.
详细描述
Cross sectional study to:
assess triglycerides/high density lipoprotein-cholesterol ratio as a novel atherogenic marker in patients presenting with acute coronary syndrome
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •all patients presented with acute coronary syndrome
排除标准
- •patients less than 18 years
- •rheumatic heart disease
- •congenital heart disease
结局指标
主要结局
Coronary care unit admission
时间窗: From date of randomization up to 1 month
Acute coronary syndrome hospitalization and cardiovascular deathes and estimated hazar ratios (HR) by use of multivariable Cox regression models
次要结局
未报告次要终点
研究者
Fatma mohamed Ahmed Anwer
Principal investigator
Sohag University
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Re-evaluating Triglycerides in Coronary Heart DiseaseCardiovascular DiseasesHeart DiseasesCoronary DiseaseHypertriglyceridemiaNCT00005442National Heart, Lung, and Blood Institute (NHLBI)
Unknown
不适用
Levels of Triglycerides and HDL-C in ACS PatientsDyslipidemia Associated With Acute Coronary SyndromeNCT03429517Assiut University120
进行中（未招募）
不适用
Function of High Density Lipoproteins in Acute Coronary SyndromesAcute Coronary SyndromeNCT01278875McGill University Health Centre/Research Institute of the McGill University Health Centre65
已完成
不适用
High Density Lipoprotein Subspecies and Coronary DiseaseCardiovascular DiseasesCoronary DiseaseCoronary ArteriosclerosisHeart DiseasesNCT00005676Tufts University2,700
已完成
2 期
A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to PatientsStable Atherothrombotic DiseaseNCT01499420CSL Limited45